Giuseppe Celenza

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 9

Top Venues

Diagnostics (Basel, Switzerland)

Antibiotics (Basel, Switzerland)

ChemMedChem

Antioxidants (Basel, Switzerland)

Università degli Studi dell'Aquila

Università degli Studi dell'Aquila (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Università degli Studi dell'Aquila Apr 01 2019

Italy

Professore Associato in Biochimica Clinica e Biologia Molecolare Clinica :: Scienze Cliniche Applicate e Biotecnologiche

Università degli Studi dell'Aquila Oct 01 2006 - Mar 31 2019

Italy

Ricercatore Universitario TI :: Biotechnological and Applied Clinical Sciences

University of Notre Dame Oct 01 2005 - Sep 30 2006

United States

Assistant Research

Education History

Università degli Studi dell'Aquila Nov 01 2002 - Oct 31 2005

Italy

PHD

Università degli Studi dell'Aquila - Jul 18 2002

Italy

MSC

Publications

Pierangelo Bellio, Simonetta De Angelis, Alessandra Piccirilli, Giulio Di Michele, Remo Barnabei, Gianfranco Amicosante, Mariagrazia Perilli, Giuseppe Celenza
Evaluation of the Analytical Performances of the Biolabo SOLEA 100 Optical Coagulometer and Comparison with the Stago STA-R MAX Analyser in the Determination of PT, APTT, and Fibrinogen. Diagnostics (Basel, Switzerland) 13 (1) (2022)
Roberto Iorio, Giuseppe Celenza, Sabrina Petricca
Multi-Target Effects of ß-Caryophyllene and Carnosic Acid at the Crossroads of Mitochondrial Dysfunction and Neurodegeneration: From Oxidative Stress to Microglia-Mediated Neuroinflammation. Antioxidants (Basel, Switzerland) 11 (6) (2022)
Pierangelo Bellio, Simonetta De Angelis, Alessandra Piccirilli, Giulio Di Michele, Remo Barnabei, Gianfranco Amicosante, Mariagrazia Perilli, Giuseppe Celenza
Evaluation of the Analytical Performances of the Biolabo SOLEA 100 Optical Coagulometer and Comparison with the Stago STA-R MAX Analyser in the Determination of PT, APTT, and Fibrinogen. Diagnostics (Basel, Switzerland) 13 (1) (2022)
Sabrina Petricca, Giuseppe Celenza, Carla Luzi, Benedetta Cinque, Anna Rita Lizzi, Nicola Franceschini, Claudio Festuccia, Roberto Iorio
Synergistic Activity of Ketoconazole and Miconazole with Prochloraz in Inducing Oxidative Stress, GSH Depletion, Mitochondrial Dysfunction, and Apoptosis in Mouse Sertoli TM4 Cells. International journal of molecular sciences 23 (10) (2022)
Pierangelo Bellio, Simonetta De Angelis, Alessandra Piccirilli, Giulio Di Michele, Remo Barnabei, Gianfranco Amicosante, Mariagrazia Perilli, Giuseppe Celenza
Evaluation of the Analytical Performances of the Biolabo SOLEA 100 Optical Coagulometer and Comparison with the Stago STA-R MAX Analyser in the Determination of PT, APTT, and Fibrinogen. Diagnostics (Basel, Switzerland) 13 (1) (2022)
Lorenza Fagnani, Lisaurora Nazzicone, Pierangelo Bellio, Nicola Franceschini, Donatella Tondi, Andrea Verri, Sabrina Petricca, Roberto Iorio, Gianfranco Amicosante, Mariagrazia Perilli, Giuseppe Celenza
Protocetraric and Salazinic Acids as Potential Inhibitors of SARS-CoV-2 3CL Protease: Biochemical, Cytotoxic, and Computational Characterization of Depsidones as Slow-Binding Inactivators. Pharmaceuticals (Basel, Switzerland) 15 (6) (2022)
Remo Barnabei, Giulio Di Michele, Antonio Cellini, Gianfranco Amicosante, Mariagrazia Perilli, Pierangelo Bellio, Alessandra Piccirilli, Giuseppe Celenza
Transient disappearance of CD19+/CD5+ B-lymphocyte clone in peripheral blood in a patient with CLL during SARS-CoV-2-related mild disease. Clinical case reports 9 (6) (2021)
Pasquale Linciano, Mattia Vicario, Ivana Kekez, Pierangelo Bellio, Giuseppe Celenza, Isabel Martín-Blecua, Jesús Blázquez, Laura Cendron, Donatella Tondi
Phenylboronic Acids Probing Molecular Recognition against Class A and Class C β-lactamases. Antibiotics (Basel, Switzerland) 8 (4) (2019)
Giuseppe Celenza, Mattia Vicario, Pierangelo Bellio, Pasquale Linciano, Mariagrazia Perilli, Antonio Oliver, Jesús Blazquez, Laura Cendron, Donatella Tondi
Phenylboronic Acid Derivatives as Validated Leads Active in Clinical Strains Overexpressing KPC-2: A Step against Bacterial Resistance. ChemMedChem 13 (7) (2018)

Giuseppe Celenza.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Giuseppe Celenza